Hepatocyte Hippo pathway activity also upregulates expression of the pro-inflammatory and pro-fibrotic gene, Cyr61/CCN1, which is highly expressed in livers of NASH patients (205). This evidence concerns the gene CCN1 and metabolic dysfunction-associated steatohepatitis.